Почетна › Беркитов лимфом › Masachuset › Boston

Kliničke studije za Беркитов лимфом u gradu Boston, MA

8 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Boston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2

Dana-Farber Cancer Institute ( Site 1013), Boston

6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2

Dana-Farber Cancer Institute, Boston

365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2

Dana-Farber Cancer Institute, Boston

366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 1

Tufts Medical Center, Boston

Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT03666000

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Тражи се учесникФаза 1

Beth Israel Deaconess Medical Center, Boston

Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2026. · NCT05544019

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Тражи се учесникФаза 1

Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2025. · NCT03595917

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2

Floating Hospital for Children at Tufts Medical Center, Boston
Dana Faber Cancer Institute/ Boston Children's Hospital, Boston

Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Boston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.